@proqr.bsky.social#BiliaryAtresia is the leading cause of liver transplantation in children. This #LiverAwarenessMonth, we’re highlighting the urgent need for new options for patients and families affected by this rare disease.
Learn more: bit.ly/4ynZ9ME
@proqr.bsky.socialThis #LiverAwarenessMonth, we’re raising awareness of #BiliaryAtresia (BA), a rare liver disease that affects newborns and young children.
For more information about BA, visit our website: bit.ly/3VykIN6
#RareDisease #PediatricLiverDisease #Axiomer #RNAEditing #LiverHealth
@proqr.bsky.socialOn Sept 30 at 11a ET join our virtual Investor and Analyst educational event “NTCP Modulation in Biliary Atresia via Liver-Targeted RNA Editing”.
For additional information about the event and to register, visit: www.proqr.com/events
@proqr.bsky.socialAxiomer Insights: Our team published findings in Scientific Reports on preclinical liver models for ADAR-mediated RNA editing. Monica from our research team discusses how model selection can inform translatability for our #Axiomer #RNAEditing platform.
Read the paper here: bit.ly/3UWJLZz
@proqr.bsky.socialProQR welcomes Chris Hart as Chief Data & AI Officer and Thomas Wolf as Strategic AI Advisor to the Board. Their appointments support our strategy to apply AI across discovery and development. AX-0811, the first AI-discovered ProQR program is now in clinical trials.
